Budapest, Hungary

Lajos Szabo

This inventor holds 45 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Richter Gedeon Vegyeszeti Gyar Rt, Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1977-1989.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 7

Forward Citations = 182(Granted Patents)


Company Filing History:


Years Active: 1977-1989

Loading Chart...
Areas of Expertise:
Alkaloids
Eburnane Derivatives
Bis-Indole Compounds
Pharmaceutical Compositions
Vincaminic Acid Esters
Cytostatic Compounds
Enantioselective Synthesis
Vasodilating Treatments
Antiphlogistic Methods
Halogenated Derivatives
Dimeric Alkaloids
Indolo-Quinolizine
45 patents (USPTO):Explore Patents

Title: The Innovative Mind of Lajos Szabo

Introduction:

Lajos Szabo, a distinguished inventor hailing from Budapest, Hungary, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Szabo's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we perceive transportation in the modern era.

Career Highlights:

With a career spanning over two decades, Szabo has consistently pushed the boundaries of technological innovation. His work in developing sustainable energy solutions has earned him global recognition and numerous accolades.

Collaborations:

Szabo has collaborated with leading research institutions and tech companies worldwide, fostering a culture of innovation and knowledge-sharing. His partnerships have led to the development of pioneering technologies that have reshaped industries.

Conclusion:

In conclusion, Lajos Szabo's relentless pursuit of innovation and his passion for creating a sustainable future through technology make him a true visionary in the world of inventors. His impact on the tech industry is profound, and his legacy will continue to inspire future generations of innovators.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…